Marshall Wace’s Eidos Therapeutics, Inc. Common Stock EIDX Stock Holding History

Marshall Wace’s Portfolio EIDX Stock Details EIDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-2,403	Closed	-$316K	–	3080
2020 Q4	$316K	Buy	+2,403	New	+$212K	﹤0.01%	1635

Marshall Wace's EIDX Position: Q1 2021 in Review

Marshall Wace sold out of Eidos Therapeutics, Inc. Common Stock (EIDX) in Q1 2021, closing a stake of 2,403 shares — an estimated $316K sold.

Marshall Wace first reported a position in EIDX in Q4 2020 and held it in 1 quarter. The position peaked at $316K in Q4 2020. 0 funds tracked by Wall St. Rank hold EIDX as of Q1 2021.

Marshall Wace reported no remaining Eidos Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
Marshall Wace sold 2,403 Eidos Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $316K.
Marshall Wace first reported a position in Eidos Therapeutics, Inc. Common Stock in Q4 2020 and held it in 1 quarter.
Marshall Wace's Eidos Therapeutics, Inc. Common Stock position peaked at $316K in Q4 2020.
0 funds tracked by Wall St. Rank held Eidos Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Marshall Wace's 13F filing for Q1 2021, filed 17 May 2021.